SecBot SecBot
S-3 ·Filed May 7, 2026

FDMT

4D Molecular Therapeutics, Inc.
NEUTRAL
Impact 4/10
Horizonweeks Processed5mo ago SEC0001193125-26-212323
Shelf registration — potential dilution
Actionable Insight • Neutral

Monitor for any prospectus supplement indicating a specific offering. The shelf provides flexibility; actual issuance would be bearish due to dilution. Given strong cash runway, any offering may be opportunistic rather than desperate. Watch insider trading and subsequent filings for clues.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
FDMT ▲ +1.18% at T+60d
NEUTRAL call +1.18% · α vs SPY -3.66% · entry $10.14 → $10.26
Entry = T+0 close
May 7, 2026
via day close
T+1d
+6.41%
call +6.41% · α +6.18%
$10.79
settled 6mo ago
T+5d
-3.25%
call -3.25% · α -4.72%
$9.81
settled 6mo ago
T+20d
-14.79%
call -14.79% · α -14.82%
$8.64
settled 5mo ago
T+60d
+1.18%
call +1.18% · α -3.66%
$10.26
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

4DMT filed a $400M shelf registration (S-3) to replace an expiring shelf, with $200M carried forward and $200M newly registered. The company has $458M cash and a cash runway into H2 2028, and no immediate offering is announced. This is a routine capital-raising vehicle, but the large size relative to $545M market cap signals potential dilution if used.

Key Financial Metrics

Offering Size
$400.0M

Key Facts

  • Shelf registration of up to $400M in common/preferred/debt/warrants/units.
  • $200M carry-forward from expiring shelf (333-273845); $200M newly registered.
  • Cash, cash equivalents, and marketable securities of $458M as of March 31, 2026.
  • Net loss of $68.8M in Q1 2026 vs $48.0M in Q1 2025.
  • No concurrent offering or pricing announced.
  • Stock price on May 6, 2026: $10.42 per share.

Financial Impact

Potential dilution up to ~73% if full $400M issued at current price ($10.42) — approximately 38.4M shares vs current shares outstanding (est. ~52M based on market cap).

dilutionshares outstanding

Risk Factors

  • Dilution risk if shelf is utilized: up to 73% dilution at current price.
  • Potential overhang on stock price due to large registered amount.
  • No specific use of proceeds disclosed; could be for general corporate purposes including R&D.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
82% bullish (17 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
S-3 Filing (Primary)0001193125-26-212323
Document: d298087dex44.htm0001193125-26-212323
Document: d298087dexfilingfees.htm0001193125-26-212323
Document: d298087dex51.htm0001193125-26-212323
9 reports for FDMT
Performance horizon
100% Hit rate @ T+1 4 of 4 directional calls Went positive at some point 4 of 4 best @ T+20▲ +31.15%Jul 18, 2026
Filters
Rows
Reports for FDMT — sortable, filterable
TypeNow
Sep 22, 2026
4w ago
Insider Cluster
BEARISH ★ 4/10
$15.00 $14.71▲ +1.93%▲ +1.85%$11.03 (+26.47%)
Aug 21, 2026
9w ago
Insider Cluster
NEUTRAL ★ 3/10
$15.39 $15.72▲ +2.14%▲ +1.82%$11.03 (−28.33%)
Jul 20, 2026
14w ago
8-K
BULLISH ★ 7/10
$11.09 $11.38▲ +2.57%▲ +1.74%$11.03 (−0.54%)
Jul 18, 2026
14w ago
Press Release
BULLISH ★ 6/10
$11.09 $11.38▲ +2.57%▲ +1.74%$11.03 (−0.54%)
Jul 5, 2026
16w ago
Institutional Cluster
NEUTRAL ★ 3/10
$12.72 $12.82▲ +0.79%▲ +1.26%$11.03 (−13.29%)
Jun 29, 2026
17w ago
8-K
BULLISH ★ 6/10
$12.88 $13.30▲ +3.26%▲ +2.48%$11.03 (−14.36%)
May 14, 2026
23w ago
EFFECT
NEUTRAL ★ 4/10
$9.81 $9.15▼ −6.73%▼ −5.50%$11.03 (+12.44%)
May 7, 2026
24w ago
S-3
NEUTRAL ★ 4/10
$10.14 $10.79▲ +6.41%▲ +6.18%$11.03 (+8.78%)
Mar 18, 2026
31w ago
Press Release
NEUTRAL ★ 3/10
$8.98 $8.61▼ −4.12%▼ −2.38%$11.03 (+22.83%)
Showing 9 of 9

US Market Status

Market Closed — Opens in 3h 6m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 7, 2026